NABsys, Inc. Appoints Steve Lombardi As Chief Executive Officer
PROVIDENCE, R.I.--(BUSINESS WIRE)--Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis, today announced it has named Steve Lombardi as the company’s President and Chief Executive Officer effective immediately. The firm has also appointed Mr. Lombardi to its Board of Directors.
The Nabsys platform utilizes semi-conductor technology to create an electronic detector that can accurately measure label-free single molecules of DNA as they pass through the device. This novel, patented approach produces extremely long read lengths in any sample without sequence-bias. The Nabsys platform simplifies genetic analysis workflow versus sequencing-by-synthesis approaches that require extensive amplification and biochemical modification of the sample DNA. The semiconductor-based manufacturing process of building detectors is highly scalable and economically favorable to both optical and biological detectors.
The combination of electronic detection, simple workflows, long read lengths and scalability enables improvements in applications like genome assembly, variant ID and especially cancer research. The simplicity and cost advantage offer interesting benefits in the application of the technology to molecular diagnostics.
“Nabsys has great technology and IP. I am eager to lead this company and its smart, dedicated team in its evolution as a company toward commercial success,” said Lombardi. “The firm has the potential to deliver unique value that can provide breakthrough benefits for the genomics community. In the short-term, as structural variation is now known to be omnipresent in healthy and diseased cells, a combination of Nabsys data and short read NGS data can answer unmet questions regarding genome structure and function. Our ability to scale our technology in cost and throughput can provide customers in research and diagnostics a long-term solution to their genomic analysis needs.”
Lombardi has been associated with the key technologies that have defined modern molecular biology and has been responsible for the largest and fastest growing product lines in the life science tools industry. He has over 35 years of experience in life sciences as a scientist, product manager, general manager and CEO at Applied Biosystems, Affymetrix, Helicos BioSciences and Real Time Genomics.
At Nabsys, Lombardi will be responsible for driving commercialization of its technology. Key to this strategy is to focus and expand the company’s early access customer program to gain insight as to the value of the technology and build early adopter support. The early access program includes key opinion leaders from institutions across the marketplace for such a technology. Lombardi is working closely with Business Development Vice President Darren Lee to expand access to the platform, while overseeing day-to-day operations with R&D Vice Presidents Steve Nurnberg and John Oliver and CFO Pete Lewis.
“As Nabsys continues to grow, we're maximizing the potential and exposure of our technology,” said Stan Rose, Ph.D., chairman of the Nabsys Board of Directors. “By adding Steve's deep life science commercialization experience, executive leadership experience and extensive industry background, he will lead the company’s overall goals to be a major supplier to the life sciences industry.”
About Nabsys
Nabsys is a private, venture-backed company based in Providence, RI. Its mission is to be the leading next generation DNA sequencing platform. The Nabsys platform enables high-throughput, low-cost detection of long read lengths of DNA. When combined with short-read sequencing, Nabsys data allows scientists to better answer questions of genome structure and function. The core of the Nabsys platform is a semiconductor-based device that electronically detects individual DNA fragments. An instrument automates the processing of multiple devices for high-throughput and ease of use. Nabsys was the first company to receive a “$1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to sequencing DNA. For more information about Nabsys, please visit www.Nabsys.com, and follow us on LinkedIn and Twitter.
Contact:
Media Contact:
For Nabsys
Mary Alfieri, 617-624-3200
Nabsys@racepointglobal.com
Help employers find you! Check out all the jobs and post your resume.